AZoLifeSciences on MSN
Rare EBV-driven B cell event may spark multiple sclerosis onset
In experimental mouse models, these surviving B cells caused local damage to myelin - the insulating layer around nerve ...
Atara Biotherapeutics (NASDAQ: ATRA) has developed Ebvallo (tabelecleucel), a novel second-line immunotherapy for Epstein–Barr virus–positive post-transplant lymphoproliferative disease (EBV-PTLD).
The immune system's reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...
The immune system’s reaction to the common Epstein-Barr virus can ultimately damage the brain and contribute to multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback